Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

aTyr Pharma, Inc. - Common Stock (NQ:ATYR)

5.990 +0.200 (+3.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,096,462
Open 5.910
Bid (Size) 6.160 (11)
Ask (Size) 6.180 (2)
Prev. Close 5.790
Today's Range 5.840 - 6.440
52wk Range 1.580 - 6.440
Shares Outstanding 54,291,754
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
5 Biotech Stocks with Highly Anticipated Pending Results
Via Stocktwits
Topics Intellectual Property
These stocks that are showing activity before the opening bell on Friday.
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill

Performance

YTD
+53.2%
+53.2%
1 Month
+15.9%
+15.9%
3 Month
+82.6%
+82.6%
6 Month
+65.9%
+65.9%
1 Year
+265.2%
+265.2%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Wondering what's happening in today's after-hours session?
Via Chartmill
What's going on in today's after hours session
Via Chartmill
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
From aTyr Pharma, Inc.
Via GlobeNewswire
Which stocks are gapping on Friday?
Via Chartmill
Earnings Scheduled For March 13, 2025
Via Benzinga
aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial Results
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
From aTyr Pharma, Inc.
Via GlobeNewswire
This aTyr Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
aTyr Pharma to Present Three Posters for Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference
From aTyr Pharma, Inc.
Via GlobeNewswire
This Toast Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma to Present at Upcoming Investor Conferences
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma’s Lead Therapeutic Candidate Efzofitimod for Pulmonary Sarcoidosis to be Featured in Best of CHEST Journals at CHEST 2024 Annual Meeting
From aTyr Pharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma to Participate in September Investor Conferences
From aTyr Pharma, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is aTyr Pharma, Inc. - Common Stock publicly traded?
Yes, aTyr Pharma, Inc. - Common Stock is publicly traded.
What exchange does aTyr Pharma, Inc. - Common Stock trade on?
aTyr Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for aTyr Pharma, Inc. - Common Stock?
The ticker symbol for aTyr Pharma, Inc. - Common Stock is ATYR on the Nasdaq Stock Market
What is the current price of aTyr Pharma, Inc. - Common Stock?
The current price of aTyr Pharma, Inc. - Common Stock is 5.990
When was aTyr Pharma, Inc. - Common Stock last traded?
The last trade of aTyr Pharma, Inc. - Common Stock was at 07/18/25 04:00 PM ET
What is the market capitalization of aTyr Pharma, Inc. - Common Stock?
The market capitalization of aTyr Pharma, Inc. - Common Stock is 325.21M
How many shares of aTyr Pharma, Inc. - Common Stock are outstanding?
aTyr Pharma, Inc. - Common Stock has 325M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.